Use of recombinant factor VIIA plus continuous infusion of recombinant factor VIII in the hemostasis of type 3 von Willebrand disease with anaphylactic anti-VWF inhibitor

被引：0
|
作者：
Suzuki, N. [1 ]
Sanda, N. [2 ]
Matsushita, T. [3 ]
Kojima, T. [4 ]
Yamamoto, K. [3 ]
Katsumi, A. [5 ]
Hirashima, K. [1 ]
Kajiura, Y. [2 ]
Takatsu, M. [2 ]
Naoe, T. [1 ]
机构：
[1] Nagoya Univ Hosp, Nagoya, Aichi, Japan
[2] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan
[3] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan
[4] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4648601, Japan
[5] Natl Ctr Geriatr & Gerontol, Dept Haematol, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-459
引用
下载
收藏
页码：665 / 665
页数：1
相关论文
共 50 条
  • [1] Continuous infusion of recombinant factor VIIa (NovoSeven®) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor
    Grossmann, RE
    Geisen, U
    Schwender, S
    Keller, F
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (04) : 633 - 634
  • [2] Use of Recombinant Factor VIIa in Inherited and Acquired von Willebrand Disease
    Sucker, Christoph
    Scharf, Ruediger E.
    Zotz, Rainer B.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (01) : 27 - 31
  • [3] Use of recombinant factor VIIa (NovoSeven(R)) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor
    Ciavarella, N
    Schiavoni, M
    Valenzano, E
    Mangini, F
    Inchingolo, F
    HAEMOSTASIS, 1996, 26 : 150 - 154
  • [4] CONTROL OF HEMOSTASIS WITH RECOMBINANT FACTOR-VIIA IN PATIENT WITH INHIBITOR TO FACTOR-VIII
    INGERSLEV, J
    FELDSTEDT, M
    SINDETPEDERSEN, S
    LANCET, 1991, 338 (8770): : 831 - 832
  • [5] Successful use of recombinant factor VIII devoid of von Willebrand factor during multiple teeth extractions in a patient with type 3 von Willebrand disease
    Sakurai, Yoshihiko
    Shima, Midori
    Imai, Yuichirou
    Omura, Shoko
    Kirita, Tadaaki
    Yoshioka, Akira
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (02) : 151 - 154
  • [6] Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report
    Yushi Chikasawa
    Takeshi Hagiwara
    Masato Bingo
    Kagehiro Amano
    Shigeru Kikuchi
    Ayano Mitsuhashi
    Keiko Shinozawa
    Katsuyuki Fukutake
    Ei Kinai
    International Journal of Hematology, 2022, 116 : 622 - 629
  • [7] Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report
    Chikasawa, Yushi
    Hagiwara, Takeshi
    Bingo, Masato
    Amano, Kagehiro
    Kikuchi, Shigeru
    Mitsuhashi, Ayano
    Shinozawa, Keiko
    Fukutake, Katsuyuki
    Kinai, Ei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (04) : 622 - 629
  • [8] Safety and efficacy of continuous infusion of a combined factor VIII -: von Willebrand factor (vWF) concentrate (Haemate-P™) in patients with von Willebrand disease
    Lubetsky, A
    Schulman, S
    Varon, D
    Martinowitz, U
    Kenet, G
    Gitel, S
    Inbal, A
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (02) : 229 - 233
  • [9] Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor
    Montoro, JB
    Altisent, C
    Pico, M
    Cabanas, MJ
    Vila, M
    Puig, LL
    HAEMOPHILIA, 1998, 4 (05) : 762 - 765
  • [10] Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII
    Rock, G
    Adamkiewicz, T
    Blanchette, V
    Poon, A
    Sparling, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (03) : 684 - 687
12345